Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 1 2021

Full Issue

Europe's Vaccine Passport Leaves Out India-Made AstraZeneca Shots

The Washington Post reports on difficulties travelers from poorer countries may face due to receiving vaccines not on the E.U.'s approved list. Meanwhile, Bloomberg notes the U.K. is set to give third doses to vulnerable patients starting in September.

The Washington Post: AstraZeneca Vaccine Doses Produced In India Not Included In Europe’s Vaccine Passport Ahead Of Launch 

The European Union’s much anticipated coronavirus digital certificate, which is intended to facilitate unrestricted movement across the continent for vaccinated travelers, will begin Thursday amid widespread confusion about how the rollout will go. But many vaccinated would-be travelers — particularly those from poorer countries — do not meet the program’s criteria because they received AstraZeneca shots produced by India’s Serum Institute, which has not been approved by E.U. regulators. (Berger, 6/30)

Bloomberg: UK Covid Booster Vaccine Shots For Vulnerable Groups May Start From September

Vulnerable groups in the U.K. may be given Covid-19 booster vaccines starting from September to maintain their immunity during the winter and help ward off new variants. The country’s independent vaccination committee recommended that the government plan to offer boosters in a two-stage program alongside the annual flu vaccination drive. The rollout will depend on further data and the guidance could change, according to the Department of Health & Social Care. (Gemmell, 6/30)

CBS News: Nearly 2,000 COVID-19 Cases In Scotland Linked To People Who Gathered To Watch Soccer 

Nearly 2,000 people who live in Scotland tested positive for COVID-19 after gathering to watch football, or soccer, this month. Many of the cases are people who traveled outside of the country to watch games. (O'Kane, 6/30)

BBC News: Disabled People Forgotten During Covid, BBC Research Reveals

Thousands of deaf and disabled people across the UK have told the BBC of the devastating impact the pandemic has had on their lives. Most said their disability had worsened and more than 2,400 said routine, often vital, medical appointments had been cancelled. More than 3,300 people took part in the research carried out by the BBC. Disability charity Scope said the findings confirmed that disabled people's needs "had been forgotten". (Clegg, 6/29)

Also —

Modern Healthcare: ECRI Wins Contract To Evaluate Drugs In Europe

Eight European countries have come together to figure out if emerging pharmaceutical treatments are worth their cost, selecting not-for-profit ECRI to create a database of clinical evidence behind those drugs. Ultimately, ECRI's findings will help Ireland, Sweden, Norway, Denmark, Netherlands, Belgium, Portugal and Switzerland to decide what drugs should be covered and at what cost. (Gillespie, 6/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF